Thetford Mines, Quebec - TheNewswire - April 9, 2020 - KDA Group Inc. (TSXV:KDA) ("KDA" or the "Corporation") is proud to announce the development of technological platforms in the cannabis field for medical purposes (the "Technological Platforms").
The Technological Platforms are part of the KDA's business model and is complementary to KDA's business of marketing and offering services and products to the pharmaceutical and medical markets.
The Corporation plans to develop four Technological Platforms and exploit them in Canada. This will consist of the development of software applications: Virtual Clinics, Virtual Pharmacy, e-Commerce for orders of medical cannabis products and Counselling Services on medical cannabis products for doctors, pharmacists and patients.
Also, the Technological Platforms will allow the Corporation to offer cannabis products for medical purposes to patients and will operate in accordance with all applicable laws, rules and regulations. KDA expects the Technological Platforms to be developed and in beta testing before September 2020.
The total size of Canada's medical cannabis market in 2016 stood at some 600 million Canadian dollars. Projections show us that the market will probably increase to around 2.4 billion dollars by 2025, a fourfold increase within eight years.1
The medical cannabis market will undoubtedly have a tremendous and continuing growth. The heart of this ecosystem is ultimately the doctor.
"As of today, the main distribution problem faced by manufacturers of medical cannabis products is that there are few doctors who dare to prescribe these products because they do not know the products, their beneficial effects and for what specific indications these products should be prescribed. Our Technological Platforms will overcome this problem!
Currently, there are around 337 known drugs on the market that interact with cannabis," said Marc Lemieux, Chief Executive Officer of KDA.
"The Corporation will retain the collaboration of the ZoomMed team for the development of these Technological Platforms. ZoomMed for more than 10 years has developed a platform for the exchange of clinical information in Canada, the USA and Kuwait, between doctors and other stakeholders in the health sector, such as patients, pharmaceutical companies, pharmacies and insurance companies.
KDA will also retain among others the services of Vigilance Sante and will make available on its Technological Platforms their excellent RxVigilance software, the essential IT tool for healthcare professionals for decision-making assistance aimed to ensure the safe and optimal use of prescription drugs.
RxVigilance offers information specially adapted to medical practice and allows quick access to all the information concerning the complete analysis of the patient profile, the side effects of drugs, drug interactions and even those related to medical cannabis.
Vigilance Sante has been developing IT tools and databases for healthcare professionals for over 30 years which are used by nearly 8,900 doctors," added Marc Lemieux, Chief Executive Officer of KDA.
ABOUT KDA GROUP
KDA Group is a leading innovation and specialized solution provider in the pharmaceutical market. Today, it is a respected name for quality and expertise among the different stakeholders in the pharmaceutical and medical sector. Its management team is guided by a vision of continuing to lead the way in Quebec while extending operations across Canada and internationally. Additional information on the Corporation is available at www.kdagroup.ca and on SEDAR at www.sedar.com.
1- New Frontier Data
- 30 -
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Chief Executive Officer
Copyright (c) 2020 TheNewswire - All rights reserved.